Barostim Neo Neuromodulation Device for Heart Failure Wins FDA Approval
CVRx, a Minneapolis, Minnesota company, won FDA approval for the first neuromodulation device designed to address heart failure. Intended as a treatment option for patients with an ejection fraction ≤35% and New York Heart Failure Classification of...
Source: Medgadget - Category: Medical Devices Authors: Medgadget Editors Tags: Cardiac Surgery Cardiology Vascular Surgery Source Type: blogs
More News: Brain | Cardiac Resynchronization Therapy | Cardiology | Cardiovascular | Cardiovascular & Thoracic Surgery | Heart | Heart Failure | Hypertension | Medical Devices | Neurology | Neurosurgery | Sports Medicine | USA Health